title: Signal that reboxetine use is linked with symptoms of peripheral ischaemia (Raynaud's syndrome).
authors.forename: David W J
authors.initials: DW
authors.lastname: Clark
authors.forename: Ana-Maria
authors.initials: AM
authors.lastname: Correa-Nunes
authors.forename: I Ralph
authors.initials: IR
authors.lastname: Edwards
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000009:adverse effects*; D005260:Female; D005385:Fingers / Q000098:blood supply*; D006801:Humans; D007511:Ischemia / Q000139:chemically induced*; D008297:Male; D009025:Morpholines / Q000009:adverse effects*; D011928:Raynaud Disease / Q000139:chemically induced*; D000077593:Reboxetine
chemical_list: D018759:Adrenergic Uptake Inhibitors; D009025:Morpholines; D000077593:Reboxetine